General and Teaching Hospital Celje Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00548288
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

General and Teaching Hospital Celje

Active Ingredients

Drugs in Phase 4 Trials (4)

bromhexine (1 trial)

empagliflozin (jardiance) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

semaglutide (Ozempic) (1 trial)

Drugs in Phase 1 Trials (1)

pamidronate (aredia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5